William S. M. Wold
#166,063
Most Influential Person Now
William S. M. Wold's AcademicInfluence.com Rankings
William S. M. Woldphilosophy Degrees
Philosophy
#9782
World Rank
#13390
Historical Rank
Logic
#6738
World Rank
#8285
Historical Rank
William S. M. Woldbiology Degrees
Biology
#13465
World Rank
#17010
Historical Rank
Virology
#337
World Rank
#344
Historical Rank
Molecular Biology
#2285
World Rank
#2319
Historical Rank
Download Badge
Philosophy Biology
William S. M. Wold's Degrees
- PhD Molecular Biology University of California, Berkeley
- Doctorate Medicine Harvard University
Why Is William S. M. Wold Influential?
(Suggest an Edit or Addition)William S. M. Wold's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- The adenovirus death protein (E3-11.6K) is required at very late stages of infection for efficient cell lysis and release of adenovirus from infected cells (1996) (417)
- The 19-kilodalton adenovirus E1B transforming protein inhibits programmed cell death and prevents cytolysis by tumor necrosis factor alpha (1992) (409)
- Adenovirus vectors for gene therapy, vaccination and cancer gene therapy. (2014) (402)
- Role of early region 3 (E3) in pathogenesis of adenovirus disease. (1989) (293)
- Region E3 of adenovirus: a cassette of genes involved in host immunosurveillance and virus-cell interactions. (1991) (266)
- The E3-11.6-kDa adenovirus death protein (ADP) is required for efficient cell death: characterization of cells infected with adp mutants. (1996) (261)
- A 14,700 MW protein from the E3 region of adenovirus inhibits cytolysis by tumor necrosis factor (1988) (254)
- Forced degradation of Fas inhibits apoptosis in adenovirus-infected cells (1998) (243)
- Immune responses to adenoviruses: viral evasion mechanisms and their implications for the clinic. (1999) (216)
- Tumor-Specific, Replication-Competent Adenovirus Vectors Overexpressing the Adenovirus Death Protein (2000) (209)
- FUNCTIONS AND MECHANISMS OF ACTION OF THE ADENOVIRUS E3 PROTEINS (2004) (199)
- A short sequence in the COOH-terminus makes an adenovirus membrane glycoprotein a resident of the endoplasmic reticulum (1987) (180)
- Syrian hamster as a permissive immunocompetent animal model for the study of oncolytic adenovirus vectors. (2006) (167)
- Thirty-one human adenovirus serotypes (Ad1-Ad31) form five groups (A-E) based upon DNA genome homologies. (1979) (157)
- The 10,400- and 14,500-dalton proteins encoded by region E3 of adenovirus function together to protect many but not all mouse cell lines against lysis by tumor necrosis factor (1991) (154)
- Immunological identification of two adenovirus 2-induced early proteins possibly involved in cell transformation (1976) (153)
- Epidermal growth factor receptor is down-regulated by a 10,400 MW protein encoded by the E3 region of adenovirus (1989) (141)
- The E1B 19,000-molecular-weight protein of group C adenoviruses prevents tumor necrosis factor cytolysis of human cells but not of mouse cells (1991) (140)
- Inhibition of TRAIL-Induced Apoptosis and Forced Internalization of TRAIL Receptor 1 by Adenovirus Proteins (2001) (140)
- Activation of intracellular proteases is an early event in TNF-induced apoptosis. (1995) (131)
- E3 transcription unit of adenovirus. (1995) (129)
- Hexadecyloxypropyl-cidofovir, CMX001, prevents adenovirus-induced mortality in a permissive, immunosuppressed animal model (2008) (127)
- Overexpression of the ADP (E3-11.6K) protein increases cell lysis and spread of adenovirus. (2003) (126)
- Tissue-Specific, Tumor-Selective, Replication-Competent Adenovirus Vector for Cancer Gene Therapy (2001) (123)
- Immunosuppression enhances oncolytic adenovirus replication and antitumor efficacy in the Syrian hamster model. (2008) (123)
- Adenovirus E1A renders infected cells sensitive to cytolysis by tumor necrosis factor. (1989) (120)
- The adenovirus E3-14.7K protein is a general inhibitor of tumor necrosis factor-mediated cytolysis. (1990) (115)
- The adenovirus E3-14.7K protein and the E3-10.4K/14.5K complex of proteins, which independently inhibit tumor necrosis factor (TNF)-induced apoptosis, also independently inhibit TNF-induced release of arachidonic acid (1996) (111)
- Mouse anti-adenovirus cytotoxic T lymphocytes. Inhibition of lysis by E3 gp19K but not E3 14.7K. (1989) (107)
- Analysis of human tonsil and cancer DNAs and RNAs for DNA sequences of group C (serotypes 1, 2, 5, and 6) human adenoviruses. (1979) (107)
- The 11,600-MW protein encoded by region E3 of adenovirus is expressed early but is greatly amplified at late stages of infection (1992) (105)
- The 10,400- and 14,500-dalton proteins encoded by region E3 of adenovirus form a complex and function together to down-regulate the epidermal growth factor receptor (1991) (105)
- Adenovirus proteins that subvert host defenses. (1994) (97)
- DNA sequence of the early E3 transcription unit of adenovirus 5. (1985) (97)
- Preparation and titration of CsCl-banded adenovirus stocks. (2007) (90)
- Adenovirus E3 14.7K protein functions in the absence of other adenovirus proteins to protect transfected cells from tumor necrosis factor cytolysis (1991) (89)
- Induction of susceptibility to tumor necrosis factor by E1A is dependent on binding to either p300 or p105-Rb and induction of DNA synthesis (1996) (88)
- Adenovirus E3-10.4K/14.5K protein complex inhibits tumor necrosis factor-induced translocation of cytosolic phospholipase A2 to membranes (1997) (84)
- The role of human adenovirus early region 3 proteins (gp19K, 10.4K, 14.5K, and 14.7K) in a murine pneumonia model (1996) (83)
- cyt gene of adenoviruses 2 and 5 is an oncogene for transforming function in early region E1B and encodes the E1B 19,000-molecular-weight polypeptide (1984) (79)
- Experimental infections of humans with wild-type adenoviruses and with replication-competent adenovirus vectors: replication, safety, and transmission (2004) (78)
- Cotton rat tumor model for the evaluation of oncolytic adenoviruses. (2005) (77)
- Specificity of the mouse cytotoxic T lymphocyte response to adenovirus 5. E1A is immunodominant in H-2b, but not in H-2d or H-2k mice. (1991) (70)
- Mapping a new gene that encodes an 11,600-molecular-weight protein in the E3 transcription unit of adenovirus 2 (1984) (69)
- Effect of Preexisting Immunity on Oncolytic Adenovirus Vector INGN 007 Antitumor Efficacy in Immunocompetent and Immunosuppressed Syrian Hamsters (2008) (67)
- Deletion mutation analysis of the adenovirus type 2 E3-gp19K protein: identification of sequences within the endoplasmic reticulum lumenal domain that are required for class I antigen binding and protection from adenovirus-specific cytotoxic T lymphocytes (1993) (67)
- Molecular mechanisms by which adenoviruses counteract antiviral immune defenses. (1990) (67)
- Characterization of mutants within the gene for the adenovirus E3 14.7-kilodalton protein which prevents cytolysis by tumor necrosis factor (1993) (66)
- Detection of adenovirus type 2-induced early polypeptides using cycloheximide pretreatment to enhance viral protein synthesis (1976) (65)
- Oncolytic (replication-competent) adenoviruses as anticancer agents (2010) (62)
- A 10,400-molecular-weight membrane protein is coded by region E3 of adenovirus (1990) (62)
- Identification and gene mapping of a 14,700-molecular-weight protein encoded by region E3 of group C adenoviruses (1988) (61)
- A 14,500 MW protein is coded by region E3 of group C human adenoviruses. (1990) (61)
- The 19-kDa glycoprotein coded by region E3 of adenovirus. Purification, characterization, and structural analysis. (1985) (60)
- The adenovirus E3 10.4K and 14.5K proteins, which function to prevent cytolysis by tumor necrosis factor and to down-regulate the epidermal growth factor receptor, are localized in the plasma membrane (1995) (58)
- INGN 007, an oncolytic adenovirus vector, replicates in Syrian hamsters but not mice: comparison of biodistribution studies (2009) (57)
- Chapter three--Syrian hamster as an animal model to study oncolytic adenoviruses and to evaluate the efficacy of antiviral compounds. (2012) (57)
- Adenovirus Methods and Protocols (1998) (57)
- Evidence that AGUAUAUGA and CCAAGAUGA initiate translation in the same mRNA region E3 of adenovirus. (1986) (57)
- Targeting Interferon-α Increases Antitumor Efficacy and Reduces Hepatotoxicity of E1A-mutated Spread-enhanced Oncolytic Adenovirus. (2007) (56)
- Adenovirus genes that modulate the sensitivity of virus‐infected cells to lysis by TNF (1993) (56)
- An Oncolytic Adenovirus Vector Combining Enhanced Cell-to-Cell Spreading, Mediated by the ADP Cytolytic Protein, with Selective Replication in Cancer Cells with Deregulated Wnt Signaling (2004) (54)
- Anticancer activity of oncolytic adenovirus vector armed with IFN-α and ADP is enhanced by pharmacologically controlled expression of TRAIL (2008) (54)
- Identification of families of overlapping polypeptides coded by early "transforming" gene region 1 of human adenovirus type 2. (1979) (53)
- Use of the Syrian hamster as an animal model for oncolytic adenovirus vectors. (2007) (52)
- The E3-11.6K protein of adenovirus is an Asn-glycosylated integral membrane protein that localizes to the nuclear membrane. (1992) (51)
- Mapping the 5' ends, 3' ends, and splice sites of mRNAs from the early E3 transcription unit of adenovirus 5. (1985) (50)
- Adenovirus region E3 proteins that prevent cytolysis by cytotoxic T cells and tumor necrosis factor. (1989) (49)
- Analysis of human tumors and human malignant cell lines for BK virus-specific DNA sequences. (1978) (48)
- [36] Human adenoviruses: Growth, purification, and transfection assay (1979) (48)
- Identification of a New Human Adenovirus Protein Encoded by a Novel Late l-Strand Transcription Unit (2007) (48)
- An acute toxicology study with INGN 007, an oncolytic adenovirus vector, in mice and permissive Syrian hamsters; comparisons with wild-type Ad5 and a replication-defective adenovirus vector (2009) (46)
- Targeting interferon-alpha increases antitumor efficacy and reduces hepatotoxicity of E1A-mutated spread-enhanced oncolytic adenovirus. (2007) (46)
- STAT2 Knockout Syrian Hamsters Support Enhanced Replication and Pathogenicity of Human Adenovirus, Revealing an Important Role of Type I Interferon Response in Viral Control (2015) (46)
- Characterization of the adenovirus E3 protein that down-regulates the epidermal growth factor receptor. Evidence for intermolecular disulfide bonding and plasma membrane localization. (1992) (45)
- Adenovirus E3-6.7K Protein Is Required in Conjunction with the E3-RID Protein Complex for the Internalization and Degradation of TRAIL Receptor 2 (2004) (45)
- Increasing the Efficacy of Oncolytic Adenovirus Vectors (2010) (44)
- A protein serologically and functionally related to the group C E3 14,700-kilodalton protein is found in multiple adenovirus serotypes (1990) (44)
- Pre-existing immunity and passive immunity to adenovirus 5 prevents toxicity caused by an oncolytic adenovirus vector in the Syrian hamster model. (2009) (44)
- Identification and peptide mapping of human adenovirus type 2-induced early polypeptides isolated by two-dimensional gel electrophoresis and immunoprecipitation. (1980) (43)
- Adenovirus type 2 early polypeptides immunoprecipitated by antisera to five lines of adenovirus-transformed rat cells (1979) (43)
- New drug on the horizon for treating adenovirus (2015) (43)
- Lung-specific expression of adenovirus E3-14.7K in transgenic mice attenuates adenoviral vector-mediated lung inflammation and enhances transgene expression. (1998) (43)
- The amino-terminal portion of CD1 of the adenovirus E1A proteins is required to induce susceptibility to tumor necrosis factor cytolysis in adenovirus-infected mouse cells (1991) (41)
- Adenovirus ADP protein (E3-11.6K), which is required for efficient cell lysis and virus release, interacts with human MAD2B. (2003) (41)
- Competition between splicing and polyadenylation reactions determines which adenovirus region E3 mRNAs are synthesized (1988) (40)
- Mutations within the ADP (E3-11.6K) Protein Alter Processing and Localization of ADP and the Kinetics of Cell Lysis of Adenovirus-Infected Cells (2003) (39)
- Adenovirus type 2 coded single-stranded DNA binding protein: in vivo phosphorylation and modification (1977) (39)
- Immunofluorescence Study of the Adenovirus Type 2 Single-Stranded DNA Binding Protein in Infected and Transformed Cells (1977) (39)
- Ganciclovir Inhibits Human Adenovirus Replication and Pathogenicity in Permissive Immunosuppressed Syrian Hamsters (2014) (38)
- Tristetraprolin induces cell cycle arrest in breast tumor cells through targeting AP-1/c-Jun and NF-κB pathway (2015) (37)
- Genetic analysis of mRNA synthesis in adenovirus region E3 at different stages of productive infection by RNA-processing mutants (1986) (37)
- Evidence for intracellular down-regulation of the epidermal growth factor (EGF) receptor during adenovirus infection by an EGF-independent mechanism (1992) (37)
- Upregulation of the Golgi protein GP73 by adenovirus infection requires the E1A CtBP interaction domain. (2002) (37)
- Inhibitors of Nucleotidyltransferase Superfamily Enzymes Suppress Herpes Simplex Virus Replication (2014) (36)
- The citric acid fermentation by Aspergillus niger: regulation by zinc of growth and acidogenesis. (1976) (36)
- Analysis of human cancer DNA's for DNA sequence of human adenovirus serotypes 3, 7, 11, 14, 16, and 21 in group B1. (1979) (36)
- Functional Analysis of the Leukemia Protein ELL: Evidence for a Role in the Regulation of Cell Growth and Survival (2001) (35)
- Adenovirus RIDβ Subunit Contains a Tyrosine Residue That Is Critical for RID-Mediated Receptor Internalization and Inhibition of Fas- and TRAIL-Induced Apoptosis (2002) (35)
- The E3-10.4K protein of adenovirus is an integral membrane protein that is partially cleaved between Ala22 and Ala23 and has a Ccyt orientation. (1992) (35)
- Structures of the Oligosaccharides of the Glycoprotein Coded by Early Region E3 of Adenovirus 2 (1981) (35)
- Viral proteins that regulate cellular signalling. (1998) (35)
- A 6700 MW membrane protein is encoded by region E3 of adenovirus type 2. (1990) (35)
- Cidofovir and brincidofovir reduce the pathology caused by systemic infection with human type 5 adenovirus in immunosuppressed Syrian hamsters, while ribavirin is largely ineffective in this model. (2014) (34)
- The adenovirus E3 14.5-kilodalton protein, which is required for down-regulation of the epidermal growth factor receptor and prevention of tumor necrosis factor cytolysis, is an integral membrane protein oriented with its C terminus in the cytoplasm (1992) (33)
- ATTAAA as well as downstream sequences are required for RNA 3'-end formation in the E3 complex transcription unit of adenovirus. (1985) (32)
- Evidence for an Adenovirus Type 2-Coded Early Glycoprotein (1978) (31)
- A 12,500 MW protein is coded by region E3 of adenovirus. (1992) (31)
- New pancreatic carcinoma model for studying oncolytic adenoviruses in the permissive Syrian hamster (2009) (30)
- Identification of a novel sequence that governs both polyadenylation and alternative splicing in region E3 of adenovirus. (1987) (30)
- The E3-6.7K protein of adenovirus is an Asn-linked integral membrane glycoprotein localized in the endoplasmic reticulum. (1993) (29)
- JE Nakayama/JE SA14-14-2 virus structural region intertypic viruses: biological properties in the mouse model of neuroinvasive disease. (2007) (28)
- Ceramide regulates SR protein phosphorylation during adenoviral infection. (2006) (28)
- Adenovirus Death Protein (ADP) Is Required for Lytic Infection of Human Lymphocytes (2013) (27)
- The signal-anchor domain of adenovirus E3-6.7K, a type III integral membrane protein, can direct adenovirus E3-gp19K, a type I integral membrane protein, into the membrane of the endoplasmic reticulum. (1994) (27)
- Inhibition of tumor necrosis factor and interferon triggered responses by DNA viruses. (1998) (26)
- Integration and transcription of group C human adenovirus sequences in the DNA of five lines of transformed rat cells. (1981) (26)
- Human adenoviruses: growth, purification, and transfection assay. (1979) (26)
- Map of cis-acting sequences that determine alternative pre-mRNA processing in the E3 complex transcription unit of adenovirus (1992) (25)
- A small deletion distant from a splice or polyadenylation site dramatically alters pre-mRNA processing in region E3 of adenovirus (1987) (25)
- Transforming Region of Group A, B, and C Adenoviruses: DNA Homology Studies with Twenty-Nine Human Adenovirus Serotypes (1979) (25)
- DNA sequences affecting specific initiation of transcription in vitro from the EIII promoter of adenovirus 2. (1982) (25)
- Pathology in Permissive Syrian Hamsters after Infection with Species C Human Adenovirus (HAdV-C) Is the Result of Virus Replication: HAdV-C6 Replicates More and Causes More Pathology than HAdV-C5 (2017) (25)
- Drug development against human adenoviruses and its advancement by Syrian hamster models. (2019) (25)
- A real-time PCR method to rapidly titer adenovirus stocks. (2007) (24)
- The adenovirus E3-14.5K protein which is required for prevention of TNF cytolysis and for down-regulation of the EGF receptor contains phosphoserine. (1992) (24)
- Analysis of Human Human Adenovirus Cancer DNA Type (1979) (23)
- Novel deletion mutants that enhance a distant upstream 5' splice in the E3 transcription unit of adenovirus 2. (1985) (23)
- Retrovirus-mediated transfer of an adenovirus gene encoding an integral membrane protein is sufficient to down regulate the receptor for epidermal growth factor (1990) (23)
- Adenovirus E3 Proteins: 14.7K, RID, and gp19K Inhibit Immune-Induced Cell Death; Adenovirus Death Protein Promotes Cell Death (1998) (23)
- Studies on early proteins and transformation proteins of human adenoviruses. (1980) (23)
- Genome expression and mRNA maturation at late stages of productive adenovirus type 2 infection (1976) (23)
- The E3-14.5K integral membrane protein of adenovirus that is required for down-regulation of the EGF receptor and for prevention of TNF cytolysis is O-glycosylated but not N-glycosylated. (1992) (22)
- Analysis of human cancers, normal tissues, and verruce plantares for DNA sequences of human papillomavirus types 1 and 2. (1981) (22)
- The role of cyclophosphamide in enhancing antitumor efficacy of an adenovirus oncolytic vector in subcutaneous Syrian hamster tumors (2013) (22)
- Characterization of an N-Terminal Non-Core Domain of RAG1 Gene Disrupted Syrian Hamster Model Generated by CRISPR Cas9 (2018) (21)
- Demonstration in Aspergillus niger of adenyl cyclase, a cyclic adenosine 3',5'-monophosphate-binding protein, and studies on intracellular and extracellular phosphodiesterases. (1974) (21)
- Cyclic AMP and citric acid accumulation by Aspergillus niger. (1973) (21)
- Valganciclovir Inhibits Human Adenovirus Replication and Pathology in Permissive Immunosuppressed Female and Male Syrian Hamsters (2015) (21)
- Integration Pattern of Human JC Virus Sequences in Two Clones of a Cell Line Established from a JC Virus-Induced Hamster Brain Tumor (1980) (21)
- Conserved primary sequences of the DNA terminal proteins of five different human adenovirus groups. (1979) (21)
- Methylation of late adenovirus 2 nuclear and messenger RNA. (1976) (20)
- Polypeptides encoded by transforming region E 1b of human adenovirus 2: immunoprecipitation from transformed and infected cells and cell-free translation of E 1b-specific mRNA. (1982) (20)
- Immunocompetent, semi-permissive cotton rat tumor model for the evaluation of oncolytic adenoviruses. (2007) (20)
- Deletion mutants that alter differential RNA processing in the E3 complex transcription unit of adenovirus. (1986) (20)
- Neuroadapted Yellow Fever Virus Strain 17D: a Charged Locus in Domain III of the E Protein Governs Heparin Binding Activity and Neuroinvasiveness in the SCID Mouse Model (2008) (19)
- Adenovirus immunoregulatory E3 proteins prolong transplants of human cells in immunocompetent mice. (2005) (18)
- Virus deletion mutants that affect a 3' splice site in the E3 transcription unit of adenovirus 2 (1985) (18)
- Transcriptome sequencing and development of an expression microarray platform for liver infection in adenovirus type 5-infected Syrian golden hamsters (2015) (18)
- Syrian hamster tumor model to study oncolytic Ad5-based vectors. (2012) (18)
- A 20,500-Dalton protein is coded by region E3 of subgroup B but not subgroup C human adenoviruses. (1995) (17)
- Analysis of human cancer DNA for DNA sequences of human adenovirus type 4. (1979) (17)
- Chimeric Japanese encephalitis virus/dengue 2 virus infectious clone: biological properties, immunogenicity and protection against dengue encephalitis in mice. (2006) (17)
- Sequence and functional analysis of the human adenovirus type 7 E3-gp19K protein from 17 clinical isolates. (1993) (17)
- Identification of adenovirus 2 early region 4 polypeptides by in vitro translation and tryptic peptide map analysis (1982) (17)
- Regulation by zinc and adenosine 3',5'-cyclic monophosphate of growth and citric acid accumulation in Aspergillus niger. (1976) (17)
- The E3-20.5K membrane protein of subgroup B human adenoviruses contains O-linked and complex N-linked oligosaccharides. (1995) (17)
- West Nile 25A virus infection of B-cell-deficient ((micro)MT) mice: characterization of neuroinvasiveness and pseudoreversion of the viral envelope protein. (2008) (15)
- USC‐087 protects Syrian hamsters against lethal challenge with human species C adenoviruses (2018) (15)
- Anti-adenoviral Artificial MicroRNAs Expressed from AAV9 Vectors Inhibit Human Adenovirus Infection in Immunosuppressed Syrian Hamsters (2017) (15)
- A multitasking oncolytic adenovirus vector. (2003) (15)
- Distinct Domains in the Adenovirus E3 RIDα Protein Are Required for Degradation of Fas and the Epidermal Growth Factor Receptor (2003) (15)
- Fine-mapping of sequences that suppress splicing in the E3 complex transcription unit of adenovirus. (1994) (15)
- Identification and characterization of a 30K protein (Ad4E3-30K) encoded by the E3 region of human adenovirus type 4. (2000) (14)
- A nonessential glycoprotein is coded by early region E3 of adenovirus type 7. (1981) (14)
- Region E3 of subgroup B human adenoviruses encodes a 16-kilodalton membrane protein that may be a distant analog of the E3-6.7K protein of subgroup C adenoviruses (1995) (14)
- Identification of a Previously Unrecognized Promoter That Drives Expression of the UXP Transcription Unit in the Human Adenovirus Type 5 Genome (2010) (13)
- Identification and characterization of the herpes simplex virus type 2 gene encoding the essential capsid protein ICP32/VP19c (1990) (13)
- Tumor Necrosis Factor α Increases Expression of Adenovirus E3 Proteins (1995) (13)
- Transforming Growth Factor β1 Receptor II Is Downregulated by E1A in Adenovirus-Infected Cells (2003) (13)
- Adenovirus RIDbeta subunit contains a tyrosine residue that is critical for RID-mediated receptor internalization and inhibition of Fas- and TRAIL-induced apoptosis. (2002) (13)
- Identification of adenovirus type 12 candidate transformation proteins by radioimmunoprecipitation with antisera to EcoRI-C-fragment transformed cells. (1979) (12)
- STAT1 Interaction with E3-14.7K in Monocytes Affects the Efficacy of Oncolytic Adenovirus (2013) (12)
- Male Syrian hamsters are more susceptible to intravenous infection with species C human adenoviruses than are females. (2018) (10)
- Adenovirus proteins that regulate susceptibility to TNF also regulate the activity of PLA2 (1994) (10)
- Cycles of Transient High-Dose Cyclophosphamide Administration and Oncolytic Adenovirus Vector Intratumoral Injection for Long Term Tumor Suppression in Syrian Hamsters (2014) (10)
- Construction and characterization of E1-minus replication-defective adenovirus vectors that express E3 proteins from the E1 region. (2002) (10)
- The effects of radiation on antitumor efficacy of an oncolytic adenovirus vector in the Syrian hamster model (2013) (9)
- Historic milestones in cancer virology. (1979) (9)
- Promotion of conidia aggregation in Aspergillus niger by cyclic AMP and 5'-GMP. (1973) (8)
- Construction of Mutations in the Adenovirus Early Region 3 (E3) Transcription Units (1999) (8)
- Characterization of distinct 5'-terminal cap structures of adenovirus type 2 early messenger ribonucleic acid and KB cell messenger ribonucleic acid. (1980) (8)
- Adenovirus mutants with splice-enhancing mutations in the E3 complex transcription unit are also defective in E3A RNA 3'-end formation (1986) (8)
- Filociclovir Is a Potent In Vitro and In Vivo Inhibitor of Human Adenoviruses (2020) (8)
- Chronic inflammatory bowel disease: absence of adenovirus DNA as established by molecular hybridization. (1981) (8)
- HAdV-C6 Is a More Relevant Challenge Virus than HAdV-C5 for Testing Antiviral Drugs with the Immunosuppressed Syrian Hamster Model (2017) (7)
- A fully replication-competent adenovirus vector with enhanced oncolytic properties (2010) (7)
- Combination therapy with brincidofovir and valganciclovir against species C adenovirus infection in the immunosuppressed Syrian hamster model allows for substantial reduction of dose for both compounds (2017) (7)
- Nucleotide sequences of 5' termini of adenovirus 2 early transforming region E1a and E1b messenger ribonucleic acids. (1981) (7)
- Association of adenovirus type 2 early proteins with a soluble complex that synthesizes adenovirus DNA in vitro. (1977) (6)
- Introduction of cloned human papillomavirus genomes into mouse cells and expression at the RNA level. (1983) (6)
- Generation and characterization of an Il2rg knockout Syrian hamster model for XSCID and HAdV-C6 infection in immunocompromised patients (2020) (6)
- The 55K protein on the 5' termini of adenovirus type 2 DNA is unrelated to virus-coded candidate transformation proteins (E1-53K, E1-40K-50K) and DNA-binding proteins (E2-42K/47K/73K) (1979) (6)
- “sarc” Sequence Transcription in Moloney Sarcoma Virus-Transformed Nonproducer Cell Lines (1979) (5)
- Tumor necrosis factor alpha increases expression of adenovirus E3 proteins. (1995) (5)
- Adenovirus and Oxaliplatin cooperate as agnostic sensitizers for immunogenic cell death in colorectal carcinoma (2019) (5)
- Adenovirus E1A and E1B-19K proteins protect human hepatoma cells from transforming growth factor beta1-induced apoptosis. (2010) (5)
- ATTAAA as well as downstream sequences are required for RNA 3'-end formation in the E3 complex transcription unit of adenovirus (1985) (5)
- Adenovirus Type 2 Early Nuclear and mRNA: Kinetic Estimation of l and r DNA Strand Fractions Complementary to Different Abundance Classes of Viral RNA (1977) (4)
- Adenovirus-2 DNA: in vitro replication and analysis of viral early proteins. (1979) (4)
- HEK? No! (2002) (3)
- Oncogenic DNA viruses--replication, tumor gene expression, and role in human cancer. (1976) (3)
- Adenovirus inhibition of immune-mediated apoptosis (1999) (2)
- Generation and characterization of an IL2RG knockout Syrian hamster model for XSCID and HAdV-C6 infection in immunocompromised patients. (2020) (2)
- The Virology of Taterapox Virus In Vitro (2018) (2)
- 121. Adenovirus Titers Determined by Quantitative Real-Time PCR Correlate with Infectious Titers (2006) (1)
- Correction: STAT2 Knockout Syrian Hamsters Support Enhanced Replication and Pathogenicity of Human Adenovirus, Revealing an Important Role of Type I Interferon Response in Viral Control (2016) (1)
- 624. Conditionally Replicative Adenovirus Vector Overexpressing the ADP (E3-11.6K) Protein and Armed with Human Interferon Alpha (2006) (1)
- 16. STAT2 Knockout Syrian Hamsters Support Enhanced Replication and Pathogenicity of Human Adenovirus Type 5, Revealing an Important Role of Type I Interferon Response in Viral Control (2016) (1)
- Adenoviruses, ad vectors, quantitation, and animal models (2007) (1)
- 1018. Immune-Competent Cotton Rat Animal Model for Evaluation of Oncolytic Adenoviruses (2004) (1)
- Mark Buller (1949–2017) (2017) (0)
- The10,400- and14,500-Dalton Proteins EncodedbyRegionE3of Adenovirus Function Together ToProtect ManybutNotAllMouse CellLinesagainst LysisbyTumorNecrosis Factor (1991) (0)
- 642. Toxicological Findings with Oncolytic Adenovirus Vector VRX-007, Wild-Type Ad5, and a Replication-Defective Adenovirus Vector in Syrian Hamsters and C57BL/6 Mice (2006) (0)
- A SmallDeletion Distant fromaSplice orPolyadenylation Site Dramatically Alters Pre-mRNAProcessing in Region E3ofAdenovirus (1987) (0)
- NPP-669, a Novel Broad-Spectrum Antiviral Therapeutic with Excellent Cellular Uptake, Antiviral Potency, Oral Bioavailability, Preclinical Efficacy, and a Promising Safety Margin (2022) (0)
- Maurice Green - A pioneering virologist. (2018) (0)
- 651. VRX-007, an Oncolytic Adenovirus Vector, Replicates in Syrian Hamsters but Not Mice: Comparison of Biodistribution Studies Performed in the Syrian Hamster and Mouse (2006) (0)
- epidermal growth factor. sufficient to down regulate the receptor for is gene encoding an integral membrane protein Retrovirus-mediated transfer of an adenovirus (2013) (0)
- 1022. Single-Dose Intravenous Toxicity Study with the Oncolytic Adenovirus Vector VRX-007, Adenovirus Type 5, and a Replication-Defective Adenovirus in Syrian Hamsters (2005) (0)
- Correction for Spurrell et al., “STAT1 Interaction with E3-14.7K in Monocytes Affects the Efficacy of Oncolytic Adenovirus” (2017) (0)
- 1023. Determination of the Maximum Tolerated Dose of the Replication-Competent Adenovirus Vector VRX-007 Following Intravenous Administration in Syrian Hamsters (2005) (0)
- The integration of human DNA and expression tumor virus genes : (cell transformation, transcription, integration, human cancer) (1980) (0)
- Synergistic effects of specially designed replication competent adenovirus vector and radiotherapy (2000) (0)
- 1021. Development of a Syrian Hamster Animal Model To Study Replication Competent Adenovirus Vectors for Cancer Gene Therapy (2005) (0)
- Identification of a New Human Adenovirus Protein Encoded by a Novel Late l -Strand Transcription Unit (cid:1) (2007) (0)
- 2035 Replication competent adnovirus anticancer vectors — Radiotherapy synergy experiment in tissue culture phase (1999) (0)
- 1011. Tumor Specific Oncolytic Adenovirus Vector VRX-011 Which Overproduces ADP and Has the E4 Promoter Replaced by the hTERT Promoter (2004) (0)
- Simplex Virus Replication Superfamily Enzymes Suppress Herpes Inhibitors of Nucleotidyltransferase (2014) (0)
- Ad proteins, RNA, lifecycle, host interactions, and phylogenetics (2007) (0)
- 447. Replication-Competent Oncolytic Adenovirus Vectors That Express TRAIL and Over-Express ADP (2004) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With William S. M. Wold?
William S. M. Wold is affiliated with the following schools:
